Response to: Is there any clinical reason to administer anticoagulant therapy to patients with the Jugular Vein Nutcracker Syndrome?
-
Published:2023-12-04
Issue:1
Volume:12
Page:
-
ISSN:2279-7483
-
Container-title:Veins and Lymphatics
-
language:
-
Short-container-title:Veins and Lymphatics
Author:
Angelini ChiaraORCID,
Mantovani Giorgio,
Scerrati AlbaORCID
Publisher
PAGEPress Publications
Subject
Automotive Engineering
Reference6 articles.
1. Siniscalchi EN, Raffa G. Is there any clinical reason to administer anticoagulant therapy to patients with the Jugular Vein Nutcracker syndrome? Veins and Lymphatics. 2023;12:12088.
2. Angelini C, Mantovani G, Cavallo MA, Scerrati A, Bonis PD. Neurosurgical implications of the Jugular Vein Nutcracker. Veins and Lymphatics. 2023;12:11892.
3. Bai C, Wang Z, Guan J, et al. Clinical characteristics and neuroimaging findings in eagle syndrome induced internal jugular vein stenosis. Ann Transl Med. 2020;8:97.
4. Debourdeau P, Farge D, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost. 2013;11:71-80.
5. Scerrati A, Menegatti E, Zamboni M, et al. Internal Jugular Vein Thrombosis: Etiology, Symptomatology, Diagnosis and Current Treatment. Diagnostics. 2021;11:378.